Micronized cellular adipose matrix as a therapeutic injectable for diabetic ulcer
This Short Communication by Jingwei Feng et al., University of Tokyo Graduate School of Medicine, Japan, researches the potential of micronized cellular adipose matrix – a bioactive injectable consisting of functional ECM and resident cells such as ASCs – to accelerate healing in ischemic diabetic ulcers.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>